Cargando…

Targeting Vascular Endothelial Growth Factor in Oesophagogastric Cancer: A Review of Progress to Date and Immunotherapy Combination Strategies

In 2014, the survival benefits seen in REGARD and RAINBOW studies led the way for the regulatory approval of ramucirumab in the second line setting in oesophagogastric (OG) cancer. Trials of other drugs targeting the vascular endothelial growth factor (VEGF) pathway have met with mixed results but t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Butters, Oliver, Young, Kate, Cunningham, David, Chau, Ian, Starling, Naureen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647870/ https://www.ncbi.nlm.nih.gov/pubmed/31380271 http://dx.doi.org/10.3389/fonc.2019.00618

Ejemplares similares

The evolving immunotherapeutic landscape in advanced oesophagogastric cancer
por: Flynn, Michael, et al.
Publicado: (2018)

Characterising timing and pattern of relapse following surgery for localised oesophagogastric adenocarcinoma: a retrospective study
por: Moorcraft, Sing Yu, et al.
Publicado: (2016)

Effect of perioperative FLOT versus ECF/ECX on short-term outcomes after surgery for resectable oesophagogastric adenocarcinoma: propensity score-matched study
por: Moussa, Osama, et al.
Publicado: (2022)

Detecting and Tracking Circulating Tumour DNA Copy Number Profiles during First Line Chemotherapy in Oesophagogastric Adenocarcinoma
por: Davidson, Michael, et al.
Publicado: (2019)

Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma: Results of the Proof-of-Concept iMYC Study
por: Turkes, Fiona, et al.
Publicado: (2022)

Immunotherapy and pancreatic cancer: unique challenges and potential opportunities
por: Young, Kate, et al.
Publicado: (2018)

Up-to-Date Tailored Systemic Treatment in Pancreatic Ductal Adenocarcinoma
por: Fong, Caroline Y. K., et al.
Publicado: (2019)

Relevance of MTHFR polymorphisms with response to fluoropyrimidine-based chemotherapy in oesophagogastric cancer: a meta-analysis
por: Zhong, Lei, et al.
Publicado: (2018)

Effectiveness of additional antireflux surgery after resection of oesophagogastric junction cancer: protocol for a systematic review and meta-analysis
por: Wang, Na, et al.
Publicado: (2022)

Current Strategies for Tumor Photodynamic Therapy Combined With Immunotherapy
por: Hua, Jianfeng, et al.
Publicado: (2021)

Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer
por: Rao, S, et al.
Publicado: (2008)

Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma
por: Xie, Shuqi, et al.
Publicado: (2023)

Impact of route to diagnosis on treatment intent and 1-year survival in patients diagnosed with oesophagogastric cancer in England: a prospective cohort study
por: Palser, Thomas R, et al.
Publicado: (2013)

Cyclooxygenase-2 Inhibitor: A Potential Combination Strategy With Immunotherapy in Cancer
por: Pu, Dan, et al.
Publicado: (2021)

FLOT and CROSS chemotherapy regimens alter the frequency of CD27(+) and CD69(+) T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy
por: Davern, Maria, et al.
Publicado: (2022)

Progress on neoadjuvant immunotherapy in resectable non-small cell lung cancer and potential biomarkers
por: Wu, Xinyu, et al.
Publicado: (2023)

Immunotherapy progress and clinical strategy of unresectable locally advanced non-small cell lung cancer
por: Zhang, Xiaofei, et al.
Publicado: (2023)

Assessment of a Noninvasive Exhaled Breath Test for the Diagnosis of Oesophagogastric Cancer
por: Markar, Sheraz R., et al.
Publicado: (2018)

Editorial: Neovascularization, Angiogenesis and Vasculogenic Mimicry in Cancer
por: López-Camarillo, César, et al.
Publicado: (2020)

Vascular normalization and immunotherapy: Spawning a virtuous cycle
por: Swamy, Kumara
Publicado: (2022)

Progression in immunotherapy for advanced prostate cancer
por: Liang, Hao, et al.
Publicado: (2023)

Radiation in Combination With Targeted Agents and Immunotherapies for Pediatric Central Nervous System Tumors - Progress, Opportunities, and Challenges
por: Qiu, Bo, et al.
Publicado: (2021)

Laparo-endoscopic combined approach for excision of gastrointestinal stromal tumour close to the oesophagogastric junction
por: Vinnicombe, Zak, et al.
Publicado: (2015)

Combinations of Immunotherapy and Radiation in Cancer Therapy
por: Vatner, Ralph E., et al.
Publicado: (2014)

Editorial: Advances in Combination Tumor Immunotherapy
por: Curran, Michael A., et al.
Publicado: (2015)

Research progress of nanovaccine in anti-tumor immunotherapy
por: Yao, Min, et al.
Publicado: (2023)

Perioperative Therapy of Oesophagogastric Adenocarcinoma: Mainstay and Future Directions
por: Bose, Katrin, et al.
Publicado: (2017)

Combination Antiangiogenic and Immunotherapy for Advanced Hepatocellular Carcinoma: Evidence to Date
por: Raybould, Alison L, et al.
Publicado: (2020)

When Is “Type I” Ovarian Cancer Not “Type I”? Indications of an Out-Dated Dichotomy
por: Salazar, Carolina, et al.
Publicado: (2018)

Clinical opportunities in combining immunotherapy with radiation therapy
por: Finkelstein, Steven E., et al.
Publicado: (2012)

Effective Combinations of Immunotherapy and Radiotherapy for Cancer Treatment
por: Yu, Siting, et al.
Publicado: (2022)

Immunotherapy Combined With Radiation Therapy for Genitourinary Malignancies
por: Ukleja, Jacob, et al.
Publicado: (2021)

Diagnostic Accuracy and Safety of Coaxial System in Oncology Patients Treated in a Specialist Cancer Center With Prospective Validation Within Clinical Trial Data
por: Khan, Khurum, et al.
Publicado: (2020)

Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer
por: Luo, Chenyi, et al.
Publicado: (2022)

Outcomes following Oesophagogastric Resections during COVID-19: A Comparative Analysis
por: Nnaji, Martin, et al.
Publicado: (2021)

Impact of tumour histological subtype on chemotherapy outcome in advanced oesophageal cancer
por: Davidson, Michael, et al.
Publicado: (2017)

Research Progresses in Immunological Checkpoint Inhibitors for Breast Cancer Immunotherapy
por: Zhang, Wenxiang, et al.
Publicado: (2021)

Microenvironment and the progress of immunotherapy in clinical practice of NSCLC brain metastasis
por: Xie, Mengqing, et al.
Publicado: (2023)

Improvement of Cancer Immunotherapy by Combining Molecular Targeted Therapy
por: Kawakami, Yutaka, et al.
Publicado: (2013)

Laparoscopic fundoplication and new aspects of neural anatomy at the oesophagogastric junction
por: Gehwolf, P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p21s8snuvfc1roph5upqcovggb